Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516916 | SCV000615265 | benign | not specified | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000556496 | SCV000656501 | benign | Developmental and epileptic encephalopathy, 30 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311839 | SCV000846503 | benign | Inborn genetic diseases | 2016-04-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004712872 | SCV005275252 | benign | not provided | criteria provided, single submitter | not provided |